Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30

FDA recall notice · announced March 6, 2013 · Dr. Reddy's Laboratories

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Notes

Distribution: Nationwide
Lot/code information: Lot #: C108376, C108634, Exp 11/13
Quantity: 48, 754 bottles (C108376)/47,520 bottles (C108634)
Status: Terminated
Products in this recall event:
- Citalopram tablets USP, 10mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-342-30 (D-178-2013)
- Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30 (D-179-2013)
- Citalopram tablets USP, 40mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-344-30 (D-180-2013)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.